Key Takeaways
- • Prime Intelliect, a San Francisco-based agentic AI platform builder, achieved unicorn status with a $1 billion valuation following a $130 million Series A round led by Radical Ventures, alongside investors including Nvidia Ventures, Intel Capital, Dell Technologies Capital, and Iconiq.
- • Venus Aerospace raised $91 million in Series B funding for hypersonic rocket engine development, with Mercury Fund leading and participation from Lockheed Martin Ventures, signaling continued institutional appetite for advanced aerospace propulsion technology.
- • Leo Cancer Care secured $65 million in Series D funding for radiation therapy devices, Yu Galaxy led, demonstrating sustained capital deployment toward healthcare medical devices addressing oncology treatment.
- • Early-stage venture ecosystem shows broad-based capital deployment across AI, aerospace, healthcare, and energy sectors, with eight distinct funding announcements ranging from €10 million to $130 million across geographies including North America, Europe, and the U.K.
Summary
The venture capital market continues to show robust deployment across multiple high-growth sectors, anchored by Prime Intelliect's achievement of unicorn valuation. The San Francisco-based agentic AI platform builder raised $130 million in Series A funding at a $1 billion post-money valuation, securing backing from Radical Ventures as lead investor alongside semiconductor and technology infrastructure players Nvidia Ventures, Intel Capital, and Dell Technologies Capital, plus wealth manager Iconiq. This funding round underscores sustained investor confidence in AI infrastructure and autonomous agent development platforms.
Beyond the headline unicorn announcement, eight additional funding events across venture stages demonstrate capital market breadth. Venus Aerospace, a Houston-based developer of rocket engines for hypersonic flight, closed a $91 million Series B led by Mercury Fund with participation from aerospace-focused Lockheed Martin Ventures, reflecting institutional interest in next-generation propulsion technology. In healthcare, Leo Cancer Care, a U.K.-based radiation therapy device manufacturer, raised $65 million in Series D funding from Yu Galaxy and Eventide Asset Management, indicating mature-stage capital for medical device solutions in oncology.
Earlier-stage activity includes Kaon AI, which raised $60 million in Series B for generative AI applications in entertainment; Vendelux, an NYC events marketing platform that secured $50 million in Series B; and three pre-Series A investments: EdVisorly ($13.3 million), Axle Energy (€21 million in distributed energy management), and Bohr Energie (€10 million in French distributed energy). The funding distribution across geographies—U.S., U.K., France, and beyond—alongside capital allocation to infrastructure, healthcare, entertainment, and energy segments indicates a diversified risk appetite within the venture ecosystem as of mid-2026.
Beyond the headline unicorn announcement, eight additional funding events across venture stages demonstrate capital market breadth. Venus Aerospace, a Houston-based developer of rocket engines for hypersonic flight, closed a $91 million Series B led by Mercury Fund with participation from aerospace-focused Lockheed Martin Ventures, reflecting institutional interest in next-generation propulsion technology. In healthcare, Leo Cancer Care, a U.K.-based radiation therapy device manufacturer, raised $65 million in Series D funding from Yu Galaxy and Eventide Asset Management, indicating mature-stage capital for medical device solutions in oncology.
Earlier-stage activity includes Kaon AI, which raised $60 million in Series B for generative AI applications in entertainment; Vendelux, an NYC events marketing platform that secured $50 million in Series B; and three pre-Series A investments: EdVisorly ($13.3 million), Axle Energy (€21 million in distributed energy management), and Bohr Energie (€10 million in French distributed energy). The funding distribution across geographies—U.S., U.K., France, and beyond—alongside capital allocation to infrastructure, healthcare, entertainment, and energy segments indicates a diversified risk appetite within the venture ecosystem as of mid-2026.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.